Hemindra Hazari, independent market expert is of the view that Midcap pharma is going to be a better bet because large cap pharma.
first published: Jul 29, 2015 04:23 pm
A collection of the most-viewed Moneycontrol videos.

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell

Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live

Live: Can Nifty reach its all-time high levels this week? | Opening Bell
You are already a Moneycontrol Pro user.

